78316-08-2 Usage
Uses
Used in Pharmaceutical Synthesis:
3H-Imidazo[4,5-b]pyridine-7-carboxylic acid is used as a key intermediate in the synthesis of pharmaceuticals for its unique structural and reactivity features. It contributes to the development of new drugs by providing a versatile building block that can be modified to create a range of bioactive compounds with potential therapeutic effects.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 3H-Imidazo[4,5-b]pyridine-7-carboxylic acid is utilized as a research compound to explore its potential interactions with biological targets. Its structure allows for the investigation of its binding affinity, selectivity, and efficacy in modulating biological processes, which is crucial for the discovery of new therapeutic agents.
Used in Drug Development:
3H-Imidazo[4,5-b]pyridine-7-carboxylic acid is employed in drug development as a precursor to create novel molecules with potential therapeutic applications. Its unique fusion of pyridine and imidazole rings offers a distinct chemical scaffold that can be optimized for specific pharmacological activities, leading to the advancement of new treatment options for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 78316-08-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,3,1 and 6 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 78316-08:
(7*7)+(6*8)+(5*3)+(4*1)+(3*6)+(2*0)+(1*8)=142
142 % 10 = 2
So 78316-08-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H5N3O2/c11-7(12)4-1-2-8-6-5(4)9-3-10-6/h1-3,5H,(H,11,12)
78316-08-2Relevant academic research and scientific papers
AMINOPYRAZINE COMPOUNDS AS HPK1 INHIBITOR AND THE USE THEREOF
-
Page/Page column 88, (2021/02/26)
Disclosed herein is an aminopyrazine compound of Formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating HPK1 related disorders or diseases by using the compound disclosed herein.
2-OXO-1-PYRROLIDINE DERIVATIVES
-
Page/Page column 132; 133, (2008/06/13)
The present invention concerns 2-oxo-1 -pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
